Discovery Experimental & Development Inc. (DEDI) was growing in mid 1992, heavily involved with research for future products, and perfecting vitamins & supplements that were already available to the public in less effective forms. DEDI had successfully developed Liquid Deprenyl Citrate, a product that has some impact against nearly 100% of nuerological diseases. DEDI's president (James Kimball) was looking to become more invovled with viruses and infections, with the strong hope of at discoverying something at least helpful for HIV.

Mr. Kimball (Kimball) was searching through substances, vitamins, supplements in hopes of discoverying something worth researching. He often checked Medline, as they posted very reliable scientific trial information, and checked on other sources for any new breakthrew trials or substances. At this point in 1992 DEDI was friendly with some doctors, institues, and universities, who knew of DEDI's morals, intentions, and goals.

It was not uncommon for personal in the medical industry or the public to contact DEDI and ask them to research something. In fact, DEDI highly encouraged this in it's own letters and literatures. DEDI had been receiving information about a cetain substance that was sometimes highly effective against infections, and other times not helpful at all. One individual in particular was intent upon DEDI researching this substance and, after speaking over the phone with this individual, Kimball thought, given the information, the substance was worth further investigation.

Kimball spent the next two weeks researching the information he was given over the phone. In particular, discoverying if similar products had been developed years prior as the caller had claimed. Kimball confirmed the statement was true and proceeded to go even far back in his research and found much more than the caller knew.

Kimball went back as far as the late 1800's when products of this nature were first discovered. He contacted a scientist that was currently at the Pasture Institute in France. That scientist advised Kimball that he believed forms of the product would be lethal against cancers. That he had researched a form of the product that he believed could be developed many years prior; presented his research to the FDA and the FDA had told him he was crazy. Directly after his meeting with the FDA he left the United States and never returned. He did however, explain to Kimball what type of device needed to be developed, and that he still believed a device of that nature would work. He told Kimball he dropped the entire research 20 years ago after being ridiculed by the FDA. He never picked up the research in France, as cancer is nowhere near as prevalent in Europe as in the U.S.

After DEDI finished the background research on products similiar to the one the caller was using, he contacted the caller and asking him to send him a sample of the product and DEDI would find out what the problem with it was. At this time, Kimball also informed the caller that DEDI was well interested in developing a product along the same lines. The caller told Kimball he juts wanted the product to work in a consistent manner. Kimball also advised the caller that since DEDI was planning to conduct research upon similar products anyway, DEDI would not charge for the research (as the caller offered) to find out why his current product was effective only sporadically.

Within two weeks DEDI had discovered why the product the caller was purchasing was only effective some of the time and not all of the time. the caller's purchased product was totally unstable and only reflected effectiveness when freshly made.

DEDI's research revealed that all the earlier versions of the products produced for the last 100 years were totally unstable; had to be used immediately to be effective; had side effects and were not nearly as effective as antibiotics, after they were developed. Thus products like the caller was purchasing all but dropped out of existence after the development of antibiotics.

DEDI believed after speaking with the scientist at the Pasture Institute and other scientists and researchers that studied the same mineral, that a version of that mineral could be produced, that would be much more effective than any antibiotics currently developed. That a new product could be stabilized which would produce no adverse side effects.

Kimball put Dr. Terrance Owen, Professor and head of the Organic Chemistry Department at the University of South Florida as head of the development of the product, assisted by another scientist/doctor professor and lecturer at Oxford University in England. These two scientists had worked exceedingly well together on other development projects for Kimball.

Months went by producing the same results as the past literature stated regarding the different variations of the product produced in the past. The products DEDI had attempted to develop all were totally unstable, contained contaminates which would cause adverse side effects, same as the ones used previously along with the current one used by the caller and other alternative doctors. The point that other alternative doctors made in using this natural mineral product in lieu of antibiotics was the fact that the mineral product produced far less side effects, than antibiotics did which had killed many people.

In the fall of 1992, Dr. Owen came to Kimball and told him he believed that he had found the natural products that would stabilize the mineral. Owen told Kimball, however that the type of mineral he was using with his new developed stabilizing agent was not the same as what DEDI was attempting to develop. Owen went on to tell Kimball that the version of the mineral was only used to test the stabilizing properties of his newly developed natural stabilizer.

After months of stability testing DEDI's research team had come up with a winner. The natural stabilizer worked perfectly. However, the mineral product within the stabilizer was not the form of the product DEDI was attempting to develop, or that could conceivably be effective against any bacteria or virus. Everyone agreed on that point.

The research team wanted to forge ahead and produce the same type product as previously produced; remove the contaminates from it and put it in the new stabilizing agent.

Kimball suggested testing the improperly made product, to see if it would have any effects against bacteria. The research team now included a scientist from the University of Toronto in Canada, who had also started working with DEDI. All stated it would be a waste of time to do the testing, but it couldn't hurt. The test results conducted at the University of South Florida revealed that it was effective against staph bacteria.

Everyone was amazed as common science suggests the product could not work. Meetings were held between the research team, and other doctors, and researchers to discuss the human use of the new product. Everyone concluded that the specific form of the mineral developed would be free of any adverse side effects and could do no harm to anyone.

Kimball made the decision to make and send a quantity of the new product to to a naturopathic doctor for trials with his patients. The results exceeded anyone's expectations. The doctor kept a record of his trials and forwarded them to DEDI.

DEDI soon made the doctor a distributor of the new product and applied to the FDA, forwarding the doctor's trial results for use of the product as an over the counter drug, under the grandfather provisions.

DEDI and the FDA were not on the best of terms at the time, so instead of the FDA contacting DEDI regarding the FDA drug registrations, the FDA contacted the doctor in Colorado.

The FDA told the doctor if he would make sure DEDI made changes in the labeling of the new product, the FDA would consider the product as a Dietary Supplement and not a drug. That they would not have to contend with DEDI requesting their product as a drug with the FDA. The doctor contacted Kimball and informed him about the the label changes the FDA requested from DEDI, which Kimball implemented. This transpired in early 1993.

It didn't take long before a good deal of the alternative doctors found out about the development of this new product through the promotions of the first alternative doctor. While the doctor's company was promoting the product, universities were conducting more testing, revealing the product's effectiveness with serious bacterial and fungal infections.

While all this was going on Kimball came in contact with a Dr. Willie Burgdorfer. Dr. Burgdorfer was the scientist who was head of the Rocky MT Division of the National Institute of Health (NIH). Dr. Burgdorfer was a renowned scientist who had discovered the spirochetes which caused lyme disease, which had been named after him.

Dr. Burgdorfer wanted some samples of different strengths of DEDI's product from the lowest to the highest strength to test their effectiveness against the spirochetes in lyme. Although Kimball never met Dr. Burgdorfer, they began working closely together to further develop DEDI's new mineral product.

Dr. Owen had left DEDI due to threats and pressure from Government and the Pharmaceutical industry officials after DEDI was raided in a combined conspiracy and all their research and products were confiscated in 1994.

Dr. Owern's assitant took over as head of research for Silvicidal with the assistance of a researcher in Toronto, and now Dr. Burgdorfer with the NIH.

Dr. Burgdorfer found the product to be effective in killing the spirochetes in Lyme disease. As Dr. Burgdorfer became more involved in learning how DEDI's product was manufactured, he explained to Kimball that he wanted to conduct more extensive research in attempts to refine the product to increase its potency and effectiveness.

When Dr. Burgdorfer completed his research, with the sophisticated equipment he had at his disposal, he advised Kimball that the current product DEDI developed, although effective, was not nearly as effective as it could be. Dr. Burgdorfer advised Kimball that DEDI's product did not have a consistent mineral size, and that he had separated and extracted all the different particle sizes out of DEDI's product and tested each one of them for their effectiveness with the lyme spirochetes.

Dr. Burgdorfer reported that some particle sizes produced no positive results, while others produced very limited positive results. However, one particle size produced astounding positive results. Dr. Burgdorfer asked Kimball if DEDI could engineer their product to be manufactured at a specific particle size. If DEDI could send him samples as fast as possible.

After many attempts, the team of doctors came up with the method of manufacture that now produced the mineral product at the designated size Dr. Burgdorfer had requested.

The product was sent to the Rocky MT NIH lab for testing. Dr. Burgdorfer advised Kimball it was the best it could be and was going to start trials immediately with rats. However, Burgdorfer's trials with the rats was stonewalled by government personnel and Dr. Burgdorfer went into retirement in disgust. This was around the end of 1994.

Production with the old product was immediately stopped, and the new revised mineral product put into production. Samples of this new product were sent to Temple University to be tested against different strains of fungi, to the University of South Florida for testing antibiotic resistant strains of bacteria and to the University of Southern California for testing against the HIV virus.

While the universities' testing was ongoing, medical doctors hearing about the product from alternative doctors started using the product orally to treat lyme disease, staph infections, food poisoning, ear infections in adults and children, sinus infections, and urinary tract infections.

All the results were positive, some not even believable, however these reports now were coming from medical doctors whose opinions were more accepted within the medical community than the licensed alternative doctors.

An in dept accounting of the development of this product and others and what the Pharmaceutical Companies, FDA, and Florida Department of health did to stop Kimball; review Kimball’s affidavit written in 1994